Othello syndrome and chronic dopaminergic treatment in patients with Parkinson's disease

Parkinsonism Relat Disord. 2014 Mar;20(3):337-9. doi: 10.1016/j.parkreldis.2013.09.001. Epub 2013 Sep 10.

Authors

Hiroshi Kataoka¹, Takao Kiriyama², Nobuyuki Eura², Nobuhiro Sawa², Satoshi Ueno²

Affiliations

¹ Department of Neurology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan. Electronic address: hk55@naramed-u.ac.jp.
² Department of Neurology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.

PMID: 24054315
DOI: 10.1016/j.parkreldis.2013.09.001

No abstract available

Publication types

Case Reports
Letter
Review

MeSH terms

Aged
Dopamine Agents / adverse effects*
Female
Humans
Male
Middle Aged
Paranoid Disorders / chemically induced
Paranoid Disorders / diagnosis*
Paranoid Disorders / psychology*
Parkinson Disease / diagnosis
Parkinson Disease / drug therapy*
Parkinson Disease / psychology*
Treatment Outcome

Substances

Dopamine Agents